[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Dhiman et al., 2010 - Google Patents

Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver

Dhiman et al., 2010

View PDF
Document ID
9457400117718215081
Author
Dhiman R
Kurmi R
Thumburu K
Venkataramarao S
Agarwal R
Duseja A
Chawla Y
Publication year
Publication venue
Digestive diseases and sciences

External Links

Snippet

Abstract Background and Aims Minimal hepatic encephalopathy is the mildest form of the spectrum of hepatic encephalopathy (HE) that impairs health-related quality of life. We assessed (1) the usefulness of psychometric hepatic encephalopathy score and critical …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature

Similar Documents

Publication Publication Date Title
Dhiman et al. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver
Kircheis et al. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy
Montgomery et al. Advances in the evaluation and management of minimal hepatic encephalopathy
Wang et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China
Hermanns et al. How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment
Crary et al. Dysphagia, nutrition, and hydration in ischemic stroke patients at admission and discharge from acute care
Mina et al. Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis
Laurin et al. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up
Daley et al. Metabolomics profiling of concussion in adolescent male hockey players: a novel diagnostic method
Kircheis et al. Assessment of low-grade hepatic encephalopathy: a critical analysis
Labenz et al. Validation of the simplified Animal Naming Test as primary screening tool for the diagnosis of covert hepatic encephalopathy
Di Filippo et al. Weight trajectories and abdominal adiposity in COVID-19 survivors with overweight/obesity
Valmorbida et al. Malnutrition is associated with increased risk of hospital admission and death in the first 18 months of institutionalization
Schrage et al. Neuron-specific-enolase as a predictor of the neurologic outcome after cardiopulmonary resuscitation in patients on ECMO
Duman et al. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions
Wunsch et al. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study
Sugimoto et al. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy
He et al. Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis
Ditisheim et al. A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
Badea et al. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES)
Nardelli et al. Hepatic encephalopathy is associated with persistent learning impairments despite adequate medical treatment: a multicenter, international study
Cohn Can bedside oculomotor (HINTS) testing differentiate central from peripheral causes of vertigo?
Chou et al. Clinical characteristics and prevalence of complications of chronic kidney disease in children: the Taiwan Pediatric Renal Collaborative study
Sharma et al. Predictors of minimal hepatic encephalopathy in patients with cirrhosis
Sharma et al. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction